Carbon monoxide (CO) confers antiproliferative effects on T cells; however, how these effects are produced remains unclear. Reactive oxygen species (ROS) have recently emerged as important modulators of T cell proliferation. In this study, we aimed to determine whether the inhibitory effects of CO on T cell proliferation are dependent on the inhibition of ROS signaling.
Results:
Pretreatment with CO-releasing molecule-2 (CORM-2) had potent inhibitory effects on mouse T cell proliferation stimulated by anti-CD3/CD28 antibodies. Interestingly, CORM-2 pretreatment markedly suppressed intracellular ROS generation as well as the activity of NADPH oxidase and mitochondrial complexes I–IV in T cells after stimulation. The inhibitory effects of CORM-2 on both ROS production and T cell proliferation were comparable with those produced by the use of antioxidant N-acetylcysteine or a combined administration of mitochondrial complex I–IV inhibitors. Moreover, increasing intracellular ROS via hydrogen peroxide supplementation largely reversed the inhibitory effect of CORM-2 on the proliferation of T cells. The inhibitory effects of CORM-2 on both cell proliferation and intracellular ROS production were also shown in a T cell proliferation model involving stimulation by allogeneic dendritic cells or phorbol 12-myristate 13-actetate/ionomycin, as well as in spontaneous cell proliferation models in EL-4 and RAW264.7 cells. In addition, CORM-2 treatment significantly inhibited T cell activation in vivo and attenuated concanavalin A-induced autoimmune hepatitis.
Innovation:
CO inhibits T cell proliferation via suppression of intracellular ROS production.
Conclusion:
The study could supply a general mechanism to explain the inhibitory effects of CO on T cell activation and proliferation, favoring its future application in T cell-mediated diseases.
Get full access to this article
View all access options for this article.
References
1.
AlmeidaAS, Figueiredo-PereiraC, and VieiraHL. Carbon monoxide and mitochondria-modulation of cell metabolism, redox response and cell death. Front Physiol, 6: 33, 2015.
2.
AlmeidaAS, QueirogaCS, SousaMF, AlvesPM, and VieiraHL. Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of Bcl-2. J Biol Chem, 287: 10761–10770, 2012.
3.
AlonsoJR, CardellachF, LopezS, CasademontJ, and MiroO. Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol, 93: 142–146, 2003.
4.
BabiorBM, LambethJD, and NauseefW. The neutrophil NADPH oxidase. Arch Biochem Biophys, 397: 342–344, 2002.
5.
BelikovAV, SchravenB, and SimeoniL. TCR-triggered extracellular superoxide production is not required for T-cell activation. Cell Commun Signal, 12: 50, 2014.
6.
BelikovAV, SchravenB, and SimeoniL. T cells and reactive oxygen species. J Biomed Sci, 22: 85, 2015.
7.
BianZ, AbdelaalAM, ShiL, LiangH, XiongL, KidderK, VenkataramaniM, CulpepperC, ZenK, and LiuY. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation. Eur J Immunol, 48: 1046–1058, 2018.
8.
ChaudhriG, ClarkIA, HuntNH, CowdenWB, and CeredigR. Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol, 137: 2646–2652, 1986.
DallasML, BoyleJP, MilliganCJ, SayerR, KerriganTL, McKinstryC, LuP, MankouriJ, HarrisM, ScraggJL, PearsonHA, and PeersC. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1. FASEB J, 25: 1519–1530, 2011.
11.
DallasML, ScraggJL, and PeersC. Inhibition of L-type Ca(2+) channels by carbon monoxide. Adv Exp Med Biol, 648: 89–95, 2009.
12.
DevadasS, ZaritskayaL, RheeSG, OberleyL, and WilliamsMS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med, 195: 59–70, 2002.
13.
FagoneP, ManganoK, CocoM, PerciavalleV, GarottaG, RomaoCC, and NicolettiF. Therapeutic potential of carbon monoxide in multiple sclerosis. Clin Exp Immunol, 167: 179–187, 2012.
14.
FagoneP, ManganoK, MammanaS, CavalliE, Di MarcoR, BarcellonaML, SalvatorelliL, MagroG, and NicolettiF. Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats. Clin Immunol, 157: 198–204, 2015.
15.
FagoneP, ManganoK, QuattrocchiC, MotterliniR, Di MarcoR, MagroG, PenachoN, RomaoCC, and NicolettiF. Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clin Exp Immunol, 163: 368–374, 2011.
16.
GutscherM, PauleauAL, MartyL, BrachT, WabnitzGH, SamstagY, MeyerAJ, and DickTP. Real-time imaging of the intracellular glutathione redox potential. Nat Methods, 5: 553–559, 2008.
17.
HehnerSP, BreitkreutzR, ShubinskyG, UnsoeldH, Schulze-OsthoffK, SchmitzML, and DrogeW. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J Immunol, 165: 4319–4328, 2000.
18.
JacksonSH, DevadasS, KwonJ, PintoLA, and WilliamsMS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol, 5: 818–827, 2004.
19.
KaminskiMM, RothD, KrammerPH, and GulowK. Mitochondria as oxidative signaling organelles in T-cell activation: physiological role and pathological implications. Arch Immunol Ther Exp (Warsz), 61: 367–384, 2013.
20.
KaminskiMM, RothD, SassS, SauerSW, KrammerPH, and GulowK. Manganese superoxide dismutase: a regulator of T cell activation-induced oxidative signaling and cell death. Biochim Biophys Acta, 1823: 1041–1052, 2012.
21.
KwonJ, ShatynskiKE, ChenH, MorandS, de DekenX, MiotF, LetoTL, and WilliamsMS. The nonphagocytic NADPH oxidase Duox1 mediates a positive feedback loop during T cell receptor signaling. Sci Signal, 3: ra59, 2010.
22.
LahdenpohjaN and HurmeM. CD28-mediated activation in CD45RA+ and CD45RO+ T cells: enhanced levels of reactive oxygen intermediates and c-Rel nuclear translocation in CD45RA+ cells. J Leukoc Biol, 63: 775–780, 1998.
LiuY, LiY, ZhangL, LiM, LiC, XueC, HuangX, and ZhouP. NF-kappaB downregulates Cbl-b through binding and suppressing Cbl-b promoter in T cell activation. J Immunol, 194: 3778–3783, 2015.
26.
LosM, SchenkH, HexelK, BaeuerlePA, DrogeW, and Schulze-OsthoffK. IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J, 14: 3731–3740, 1995.
27.
Mackern-ObertiJP, LlanosC, CarrenoLJ, RiquelmeSA, JacobelliSH, AnegonI, and KalergisAM. Carbon monoxide exposure improves immune function in lupus-prone mice. Immunology, 140: 123–132, 2013.
28.
ManganoK, CavalliE, MammanaS, BasileMS, CaltabianoR, PesceA, PuleoS, AtanasovAG, MagroG, NicolettiF, and FagoneP. Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis. J Cell Physiol, 233: 4156–4165, 2018.
29.
McLennanHR and Degli EspostiM. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr, 32: 153–162, 2000.
30.
MerzTM, PereiraAJ, SchurchR, SchefoldJC, JakobSM, TakalaJ, and DjafarzadehS. Mitochondrial function of immune cells in septic shock: a prospective observational cohort study. PLoS One, 12: e0178946, 2017.
31.
Moro-GarciaMA, MayoJC, SainzRM, and Alonso-AriasR. Influence of inflammation in the process of T lymphocyte differentiation: proliferative, metabolic, and oxidative changes. Front Immunol, 9: 339, 2018.
32.
MotterliniR and OtterbeinLE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov, 9: 728–743, 2010.
33.
MuriJ, HeerS, MatsushitaM, PohlmeierL, TortolaL, FuhrerT, ConradM, ZamboniN, KisielowJ, and KopfM. The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation. Nat Commun, 9: 1851, 2018.
34.
MurphyMP and SiegelRM. Mitochondrial ROS fire up T cell activation. Immunity, 38: 201–202, 2013.
35.
NaitoY, TakagiT, UchiyamaK, KatadaK, and YoshikawaT. Multiple targets of carbon monoxide gas in the intestinal inflammation. Arch Biochem Biophys, 595: 147–152, 2016.
36.
NikolicI, SaksidaT, ManganoK, VujicicM, StojanovicI, NicolettiF, and Stosic-GrujicicS. Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects. Diabetologia, 57: 980–990, 2014.
OtterbeinLE, SoaresMP, YamashitaK, and BachFH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol, 24: 449–455, 2003.
39.
OzakiKS, KimuraS, and MuraseN. Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation. Transplant Rev (Orlando), 26: 125–139, 2012.
40.
PadgettLE and TseHM. NADPH oxidase-derived superoxide provides a third signal for CD4 T cell effector responses. J Immunol, 197: 1733–1742, 2016.
41.
PaeHO, OhGS, ChoiBM, ChaeSC, KimYM, ChungKR, and ChungHT. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol, 172: 4744–4751, 2004.
42.
PeersC, BoyleJP, ScraggJL, DallasML, Al-OwaisMM, HettiarachichiNT, EliesJ, JohnsonE, GamperN, and SteeleDS. Diverse mechanisms underlying the regulation of ion channels by carbon monoxide. Br J Pharmacol, 172: 1546–1556, 2015.
RethM. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol, 3: 1129–1134, 2002.
45.
RuanY, WangL, ZhaoY, YaoY, ChenS, LiJ, GuoH, MingC, GongF, and ChenG. Carbon monoxide potently prevents ischemia-induced high-mobility group box 1 translocation and release and protects against lethal renal ischemia-reperfusion injury. Kidney Int, 86: 525–537, 2014.
46.
SenaLA, LiS, JairamanA, PrakriyaM, EzpondaT, HildemanDA, WangCR, SchumackerPT, LichtJD, PerlmanH, BrycePJ, and ChandelNS. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity, 38: 225–236, 2013.
47.
SignesA and Fernandez-VizarraE. Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes. Essays Biochem, 62: 255–270, 2018.
48.
SimeoniL and BogeskiI. Redox regulation of T-cell receptor signaling. Biol Chem, 396: 555–568, 2015.
49.
SongR, MahidharaRS, LiuF, NingW, OtterbeinLE, and ChoiAM. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol, 27: 603–610, 2002.
50.
SongR, MahidharaRS, ZhouZ, HoffmanRA, SeolDW, FlavellRA, BilliarTR, OtterbeinLE, and ChoiAM. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol, 172: 1220–1226, 2004.
51.
TailleC, El-BennaJ, LanoneS, BoczkowskiJ, and MotterliniR. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem, 280: 25350–25360, 2005.
52.
TakagiT, NaitoY, InoueM, AkagiriS, MizushimaK, HandaO, KokuraS, IchikawaH, and YoshikawaT. Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1. Inflammation, 32: 83–88, 2009.
53.
TakagiT, NaitoY, MizushimaK, AkagiriS, SuzukiT, HirataI, OmatsuT, HandaO, KokuraS, IchikawaH, and YoshikawaT. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-alpha expression. Dig Dis Sci, 55: 2797–2804, 2010.
54.
TatlaS, WoodheadV, ForemanJC, and ChainBM. The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. Free Radic Biol Med, 26: 14–24, 1999.
55.
TsaiMH, LeeCW, HsuLF, LiSY, ChiangYC, LeeMH, ChenCH, LiangHF, HowJM, ChangPJ, WuCM, and LeeIT. CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression. Redox Biol, 12: 377–388, 2017.
56.
ValkoM, LeibfritzD, MoncolJ, CroninMT, MazurM, and TelserJ. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39: 44–84, 2007.
WangH, YaoH, LiC, LiangL, ZhangY, ShiH, ZhouC, ChenY, FangJY, and XuJ. PD-L2 expression in colorectal cancer: independent prognostic effect and targetability by deglycosylation. Oncoimmunology, 6: e1327494, 2017.
59.
WuL and WangR. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev, 57: 585–630, 2005.
60.
ZuckerbraunBS, ChinBY, BilbanM, d'AvilaJC, RaoJ, BilliarTR, and OtterbeinLE. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J, 21: 1099–1106, 2007.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
